Aspha J. Dada is listed as an executive officer and director on 2 SEC Form D filings by 1 issuer between Nov 2015 and Mar 2016: Biopep Solutions Inc. (Richmond, British Columbia, Canada (as filed: A1) — biotechnology — 2015–2016; $15K reported sold to 1 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Ahmed Merzouk (2 shared filings), Gary Yalloway (2 shared filings), Suzanne Stratton (2 shared filings) and Yalcin Ilsever (2 shared filings).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Aspha. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 2 public filings for Aspha J. Dada and found 1 difference: Form D filed 60 days after the first sale.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.